Skip to content
GenoLensGenoLens

SLC32A1

Chr 20q11.23

solute carrier family 32 member 1

Aliases:
VGAT, bA122O1.1
MANE:
ENST00000217420.2

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • developmental and epileptic encephalopathy 114

    0.64
  • generalized epilepsy with febrile seizures plus, type 12

    0.58
  • generalized epilepsy with febrile seizures plus

    0.48
  • early-infantile DEE

    0.38
  • Generalized epilepsy with febrile seizures-plus

    0.38
  • Intellectual disability

    0.38
  • Seizure

    0.37
  • restless legs syndrome

    0.29
  • neurodegenerative disease

    0.26
  • autoimmune disorder of central nervous system

    0.25

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Vesicular inhibitory amino acid transporter

Antiporter that exchanges vesicular protons for cytosolic 4-aminobutanoate or to a lesser extend glycine, thus allowing their secretion from nerve terminals. The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity). Acidification of GABAergic synaptic vesicles is a prerequisite for 4-aminobutanoate uptake (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.